Sandoz and Pear Therapeutics announced the launch of reSET-O, a new digital therapeutic for patients aged ≥18 years with opioid use disorder (OUD) currently under clinician care.
Investigators examined the effects of a person-centered music listening intervention on mood, agitation, and social engagement in people living with dementia.
Clinicians should be discerning when evaluating meta-analyses of schizophrenia add-on therapies such as statins and antidepressants.
Researchers studied the relationship between self-reported cognitive complaints and work functioning in employed patients with major depressive disorder treated with desvenlafaxine.
Patients with spondylosis, intervertebral disk disorders, and other back issues and comorbid depression may have greater healthcare expenditures than those without the comorbidity.